Replies to post #160 on Synaptogenix Inc (SNPX)

[runncoach]

Maybe this thing trades at a quarter because there hasn't been a significant Alzheimers discovery in 15-20 years. Removing the plaques hasn't worked. I'm sure most figure the odds of a small company like this succeeding are close to nothing if the major drug companies can't make a breakthrough find. Good chance they are right, but this drug comes at is from a different angle. Research on Bryostatin proves that. Will it work? Maybe not, but if is shows virtually any improvement in even a small group in this trial, it should be approved for "compassionate use" if nothing else and continue to be studied and refined to better help the affected. I figure its worth a small gamble. JMHO